Westford, USA, Sept. 27, 2024 (GLOBE NEWSWIRE) -- SkyQuest projects that Peptide Therapeutics Market will attain the value of USD 68.4 Billion by 2031, with a CAGR of 5.94% during the forecast period (2024-2031). The adoption of peptide therapies will affect the increased incidence of cancer as well as metabolic diseases such as osteoporosis, obesity and diabetes. Advanced peptides are currently being developed and modified to treat COVID-19. Researchers from around the world are searching for compounds that reduce infectious conditions or inhibit mechanisms involved in the acute and recurrent respiratory infections. Peptide drugs containing chemically synthesized polypeptides larger than 40 amino acids but shorter than 100 amino acids could have a significant impact on the market.
Browse in-depth TOC on " Peptide Therapeutics Market "
- Pages – 242
- Tables - 126
- Figures – 76
Explore Comprehensive Insights into The Global Peptide Therapeutics Market with A Detailed Sample Report: https://www.skyquestt.com/sample-request/peptide-therapeutics-market
Peptide Therapeutics Market Overview:
| Report Coverage | Details |
| Market Revenue in 2023 | USD 43.11 Billion |
| Estimated Value by 2031 | USD 68.4 Billion |
| Growth Rate | Poised to grow at a CAGR of 5.94% |
| Forecast Period | 2024–2031 |
| Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Application, Type of Manufacturers, Type, Route of Administration, Synthesis Technology and Region |
| Geographies Covered | North America, Europe, Asia Pacific, Middle East & Africa, Latin America |
| Report Highlights | Updated financial information / product portfolio of players |
| Key Market Opportunities | Rising Awareness Levels Relating to Peptide Therapeutic Products |
| Key Market Drivers | Increasing Prevalence of Cancer and Metabolic Disorders |
Peptide Therapeutics Market Segmental Analysis
Global peptide therapeutics market is segmented on the basis of application, type, type of manufacturers, route of administration, synthesis technology, and region.
By application, the market is segmented into cancer, metabolic, cardiovascular disorder, respiratory, GIT, anti-infection, pain, dermatology, CNS, renal, and others.
By type, the market is segmented into generic and innovative.
By type of manufacturers, the market is segmented into in-house and outsourced.
By route of administration, the market is segmented into parental, oral, pulmonary, mucosal, and others.
By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
In-house Segment to Dominate Due to Rising Investment and Promotion of Innovation
The in-house segment dominated the market with the highest market share of 64.7% in 2023 during the forecast period. Advances in the facility enable companies to retain complete control over their intellectual property, such as unique peptides and pharmaceutical processes and these services are critical to funding a protection of investment and promotion of innovation. Moreover, firms can have more ownership than the cost of domestic development.
Ask for Customization: https://www.skyquestt.com/speak-with-analyst/peptide-therapeutics-market
Generic Segment to Drive Market Due to Increased Federal Government Spending
The generic segment is expected to expand rapidly over the forecast period. Rising healthcare expenditures and increased federal government spending on healthcare are expected to boost the uptake of generic drugs. The main factor for the generic movement is also thought to be the loss of protection for many branded drugs. However, brand loyalty can affect companies’ growth with some new drugs.
North America is Growing Due to Rapid Technological Advancements in Region
The peptide therapeutics market was dominated by North America in 2021. The rise of the regional market is primarily due to the expansion of the biotechnology industry, growing diagnostics for cancer and other diseases, and growing consumer awareness of peptide therapeutic products. In addition, it is estimated that increased government spending on R&D will help peptide therapeutics remain dominant over the forecast period. The well-established biotechnology and pharmaceutical sectors contribute majorly to the expansion. According to the American Cancer Society, in 2022, more than 1.9 million people in the United States are expected to be diagnosed with cancer.
Drivers
- Increasing Prevalence of Cancer
- Rising Investments in Research and Development of Novel Drugs
- Increasing Prevalence of Metabolic Disorders
Restraints
- Instability of Peptides
- High Cost of Developing Drugs
- Stringent Regulatory Requirements for Drug Approval
Prominent Players in Peptide Therapeutics Market
- Amgen, Inc.
- AstraZeneca plc
- Bachem Holding AG
- Bristol-Myers Squibb Company
- Eli Lilly and Company
- Ipsen S.A.
- Merck & Co., Inc.
- Novartis AG
- Novo Nordisk A/S
- Pfizer Inc.
- Sanofi S.A.
- Takeda Pharmaceutical Company Limited
- Teva Pharmaceutical Industries Ltd.
- Lonza Group AG
- Ferring Pharmaceuticals, Inc.
- PolyPeptide Group
- Protagonist Therapeutics, Inc.
- Ipsen Biopharmaceuticals, Inc.
- Polytherapeutics Inc.
- Zealand Pharma A/S
Take Action Now: Secure Your Peptide Therapeutics Market Today - https://www.skyquestt.com/buy-now/peptide-therapeutics-market
Key Questions Answered in Peptide Therapeutics Market Report
- How big is the global Peptide Therapeutics Market?
- What are the key drivers of the global Peptide Therapeutics Market size?
- Which is the fastest growing region in the global Peptide Therapeutics Market?
This report provides the following insights:
Analysis of key drivers (increasing prevalence of cancer and metabolic disorders, rising investments in research and development of novel drugs, technological advancements), restraints (high cost of developing drugs stringent regulatory requirements for drug approval), opportunities (rising awareness levels relating to peptide therapeutic products) influencing the growth of Peptide Therapeutics Market.
- Market Dynamics: Comprehensive information about the various products offered by the dominant players in the Peptide Therapeutics Market.
- Product Development/Innovation: An overview of emerging trends, R&D activities and product launches in the Peptide Therapeutics Market.
- Market Growth: Detailed information on profitable growing industries.
- Market Trends: Complete information about new products, emerging geographical areas and recent developments in the market.
- Competitive Analysis: An in-depth analysis of the market segments, growth strategies, revenue analysis, and products of the key market players.
Read Full Report Here - https://www.skyquestt.com/report/peptide-therapeutics-market
Related Reports:
Retinal Disease Therapeutics Market is growing at a CAGR of 9.3% in the forecast period (2024-2031)
Hyperphosphatemia Therapeutics Market is growing at a CAGR of 6.5% in the forecast period (2024-2031)
Lung Cancer Therapeutics Market is growing at a CAGR of 13.2% in the forecast period (2024-2031)
Myocardial Infarction (MI) Therapeutics Market is growing at a CAGR of 4.82% in the forecast period (2024-2031)
Ophthalmic Disease Therapeutics Market is growing at a CAGR of 6.10% in the forecast period (2024-2031)
About Us:
SkyQuest is an IP focused Research and Investment Bank and Accelerator of Technology and assets. We provide access to technologies, markets and finance across sectors viz. Life Sciences, CleanTech, AgriTech, NanoTech and Information & Communication Technology.
We work closely with innovators, inventors, innovation seekers, entrepreneurs, companies and investors alike in leveraging external sources of R&D. Moreover, we help them in optimizing the economic potential of their intellectual assets. Our experiences with innovation management and commercialization have expanded our reach across North America, Europe, ASEAN and Asia Pacific.
Contact:
Mr. Jagraj Singh
Skyquest Technology
1 Apache Way,
Westford,
Massachusetts 01886
USA (+1) 351-333-4748
Email: sales@skyquestt.com
Visit Our Website: https://www.skyquestt.com/
